The risky body mass index ranges for significant hepatitis B viral load: A campus-based study

Obesity Research and Clinical Practice

Volumn 6, Issue 1, 2012, Pages

  Chiang, Chien Hsieh ^a,b   Lai, Jin Shin ^a,b   Sheu, Jin Chuan ^a,c   Yen, Lee Lan ^b   Liu, Chun Jen ^a,c   Huang, Kuo Chin ^a,b,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Liver Disease Prevention and Treatment Research Foundation   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Body mass index; HBV DNA; Insulin resistance; Risk factor; Taiwan

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; HEPATITIS B(E) ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD; WAIST CIRCUMFERENCE;

HEPATITIS B VIRUS;

EID: 84856105973     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2011.04.005     Document Type: Article

References (36)

1. Y.H. Ni, L.M. Huang, M.H. Chang, C.J. Yen, C.Y. Lu, and S.L. You Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies Gastroenterology 132 2007 1287 1293
2. Y.C. Chien, C.F. Jan, H.S. Kuo, and C.J. Chen Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched Epidemiol Rev 28 2006 126 135
3. C.J. Chen, H.I. Yang, J. Su, C.L. Jen, S.L. You, and S.N. Lu Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 2006 65 73 (Pubitemid 43042691)
4. U.H. Iloeje, H.I. Yang, J. Su, C.L. Jen, S.L. You, and C.J. Chen Predicting cirrhosis risk based on the level of circulating hepatitis B viral load Gastroenterology 130 2006 678 686 (Pubitemid 43374518)
5. C.J. Chen, H.I. Yang, and U.H. Iloeje Hepatitis B virus DNA levels and outcomes in chronic hepatitis B Hepatology 49 2009 S72 S84
6. Y.F. Liaw, and C.M. Chu Hepatitis B virus infection Lancet 373 2009 582 592
7. A. Shlomai, and Y. Shaul The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon Med Hypotheses 71 2008 53 57
8. Y.C. Lin, L.L. Yen, S.Y. Chen, M.D. Kao, M.S. Tzeng, and P.C. Huang Prevalence of overweight and obesity and its associated factors: findings from National Nutrition and Health Survey in Taiwan, 1993-1996 Prev Med 37 2003 233 241
9. N.F. Chu Prevalence of obesity in Taiwan Obes Rev 6 2005 271 274
10. K.C. Huang Obesity and its related diseases in Taiwan Obes Rev 9 Suppl. 1 2008 32 34
11. S.L. Yen, T.Y. Chiu, Y.C. Lin, Y.C. Lee, L.T. Lee, and K.C. Huang Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen Int J Obes (Lond) 32 2008 474 480
12. G.L. Wong, V.W. Wong, P.C. Choi, A.W. Chan, A.M. Chim, and K.K. Yiu Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B Gut 58 2009 111 117
13. C.L. Chen, H.I. Yang, W.S. Yang, C.J. Liu, P.J. Chen, and S.L. You Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan Gastroenterology 135 2008 111 121
14. M. Inoue, N. Kurahashi, M. Iwasaki, Y. Tanaka, M. Mizokami, and M. Noda Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II) Cancer Causes Control 20 2009 741 750
15. WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies Lancet 363 2004 157 163
16. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
17. M. Kumar, A. Choudhury, N. Manglik, S. Hissar, A. Rastogi, and P. Sakhuja Insulin resistance in chronic hepatitis B virus infection Am J Gastroenterol 104 2009 76 82
18. C.J. Chu, T.H. Hung, S.J. Hwang, Y.J. Wang, C.F. Yang, and H.C. Lin Association of insulin resistance with hepatic steatosis and progression of fibrosis in Chinese patients with chronic hepatitis C Hepatogastroenterology 55 2008 2157 2161
19. M.F. Chen, H.M. Lin, and C.K. Chou Insulin dominantly suppresses hepatitis B virus gene expression in cultured human hepatoma cells J Biomed Sci 4 1997 295 299
20. T. McLaughlin, G. Allison, F. Abbasi, C. Lamendola, and G. Reaven Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals Metabolism 53 2004 495 499 (Pubitemid 38419194)
21. H. Ohnishi, S. Saitoh, S. Takagi, J. Ohata, H. Takeuchi, and T. Isobe Incidence of insulin resistance in obese subjects in a rural Japanese population: the Tanno and Sobetsu study Diabetes Obes Metab 7 2005 83 87
22. A. Shlomai, and Y. Shaul The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription Biochem Biophys Res Commun 381 2009 544 548
23. F. Marra, and C. Bertolani Adipokines in liver diseases Hepatology 50 2009 957 969
24. R.R. Banerjee, S.M. Rangwala, J.S. Shapiro, A.S. Rich, B. Rhoades, and Y. Qi Regulation of fasted blood glucose by resistin Science 303 2004 1195 1198 (Pubitemid 38233585)
25. F. Andreelli, M. Foretz, C. Knauf, P.D. Cani, C. Perrin, and M.A. Iglesias Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin Endocrinology 147 2006 2432 2441
26. B.B. Yeap, S.A. Chubb, Z. Hyde, K. Jamrozik, G.J. Hankey, and L. Flicker Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study Eur J Endocrinol 161 2009 591 598
27. A.M. Traish, R.J. Feeley, and A. Guay Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction FEBS J 276 2009 5755 5767
28. V. Kupelian, F.J. Hayes, C.L. Link, R. Rosen, and J.B. McKinlay Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups J Clin Endocrinol Metab 93 2008 3403 3410
29. E.L. Ding, Y. Song, V.S. Malik, and S. Liu Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis JAMA 295 2006 1288 1299
30. E.L. Ding, Y. Song, J.E. Manson, D.J. Hunter, C.C. Lee, and N. Rifai Sex hormone-binding globulin and risk of type 2 diabetes in women and men New Engl J Med 361 2009 1152 1163
31. W.J. Yang, C.J. Chang, S.H. Yeh, W.H. Lin, S.H. Wang, and T.F. Tsai Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways Hepatology 49 2009 1515 1524
32. S.H. Wang, S.H. Yeh, W.H. Lin, H.Y. Wang, D.S. Chen, and P.J. Chen Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B Hepatology 50 2009 1392 1402
33. V.W. Wong, G.L. Wong, J. Yu, P.C. Choi, A.W. Chan, and H.Y. Chan Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese Am J Gastroenterol 105 2009 132 138
34. C.M. Chu, S.J. Hung, J. Lin, D.I. Tai, and Y.F. Liaw Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels Am J Med 116 2004 829 834 (Pubitemid 38721324)
35. Y.H. Ni Natural history of hepatitis B virus infection: pediatric perspective J Gastroenterol 46 2011 1 8
36. Liver EAFTSOT EASL Clinical Practice Guidelines: management of chronic hepatitis Brit J Hepatol 50 2009 227 242